非小egfr耐药逆转之met

met扩增作为egfr tki耐药的原因之一早已尘埃落定。研究文章众多。临床试验也有xl184、280等。

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib-2007
met扩增与吉非替尼获得性耐药。